Debates between Caroline Dinenage and Toby Perkins during the 2017-2019 Parliament

Oral Answers to Questions

Debate between Caroline Dinenage and Toby Perkins
Tuesday 15th January 2019

(5 years, 11 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Toby Perkins Portrait Toby Perkins (Chesterfield) (Lab)
- Hansard - - - Excerpts

4. What recent assessment he has made of the effectiveness of primary care in diagnosing fibromyalgia; and if he will make a statement.

Caroline Dinenage Portrait The Minister for Care (Caroline Dinenage)
- Hansard - -

Diagnosing fibromyalgia can be difficult because there is no specific diagnostic test and symptoms can vary. A range of support exists to help GPs, including an e-learning course developed by the Royal College of General Practitioners and Versus Arthritis, and a medical guide on diagnosis and treatment developed by Fibromyalgia Action UK.

Toby Perkins Portrait Toby Perkins
- Hansard - - - Excerpts

I am grateful to the Minister for that answer. I just hot-footed it here from Westminster Hall, where an excellent debate on fibromyalgia took place this morning. We heard a huge amount of evidence about people who suffer with fibromyalgia having waited more than a year to be diagnosed and having received treatments irrelevant to their condition. Clearly, diagnosis is not working at the moment. What more can the Minister tell us about investment in research to improve diagnosis and to try to get better outcomes for fibromyalgia sufferers?

Caroline Dinenage Portrait Caroline Dinenage
- Hansard - -

I feel that my colleague the Secretary of State has set the bar for compliments to Members this morning. On that basis, I congratulate the hon. Gentleman on his Westminster Hall debate, which raised a key issue. The Department’s National Institute for Health Research welcomes funding applications for research into any aspect of human health, including fibromyalgia. Its support for that research over the past five years includes £1.8 million funding for research projects and £0.6 million funding for clinical trials through the clinical research network.